UPDATE : Monday, September 7, 2020
Cellivery sure to win licensing deal with top pharma company
“A global pharmaceutical company is conducting a verification test on thera...
by Jeong Sae-im  |  2020-05-07 11:27
Theragen Bio starts as independent company
Theragen Bio, a spin-off firm of Theragen Etex, officially launched on Mond...
by Shim Hyun-tai  |  2020-05-06 17:24
Kolon begins testing gene therapy for neuropathic pain in US
Kolon Life Science said Monday it has started the administration of an expe...
by Jeong Sae-im  |  2020-04-27 16:18
Pharmicell’s sales to rise with commercial supply of mPEG
Pharmicell said Friday that it has made the first shipments according to th...
by Shim Hyun-tai  |  2020-04-24 18:10
Herzuma wins 40% of market share in Japan
Celltrion HealthCare said Monday that its biosimilar Herzuma (Ingredient: t...
by Shim Hyun-tai  |  2020-04-21 16:42
‘Stem cell therapy more effective on Covid-19’
“I don’t know why people pay attention only to vaccines and treatments agai...
by Jeong Sae-im  |  2020-04-21 11:01
‘Natural Killer cells predict immunotherapy’s efficacy in lung cancer patients’
Local researchers said the number of natural killer cells and their high ac...
by Jeong Sae-im  |  2020-04-17 16:07
Samsung Bioepis launches anticancer biosimilar in US
Samsung Bioepis said Thursday that it has launched Ontruzant (Ingredient: t...
by Shim Hyun-tai  |  2020-04-16 17:32
What are the odds for successful Invossa trials in US?
Pharmaceutical industry observers are closely following whether Kolon Life ...
by Jeong Sae-im  |  2020-04-14 15:01
Celltrion gets antibody candidates neutralizing new coronavirus
Celltrion said Monday that it has succeeded in securing the final antibody ...
by Shim Hyun-tai  |  2020-04-13 18:16
FDA OKs resumption of phase-3 Invossa trial in US
Kolon Life Science said the U.S. Food and Drug Administration has allowed t...
by Jeong Sae-im  |  2020-04-13 11:58
Samsung signs contract with Vir to make COVID-19 treatment
Samsung Biologics said Friday that it has signed a letter of intent with Vi...
by Shim Hyun-tai  |  2020-04-10 18:07
No Korean firms have entered trials to test COVID-19 drug candidates
Korean pharmaceutical and biotech companies have jumped in developing treat...
by Jeong Sae-im  |  2020-04-08 16:15
Samsung Biologics signs CDO contract with PharmAbcine
Samsung Biologics said Monday that it has signed a contract developing orga...
by Shim Hyun-tai  |  2020-04-06 18:00
AbClon draws many new human antibodies to fight COVID-19
AbClon, a company specializing in developing antibodies, said Monday that i...
by Shim Hyun-tai  |  2020-03-30 17:47
ImmuneMed under fire for inflating drug’s effect against COVID-19
ImmuneMed, a local biotech firm, has come under criticism for exaggerating ...
by Jeong Sae-im  |  2020-03-27 11:49
Warrant sought to arrest Medytox CEO for illegally making, selling Meditoxin
Prosecutors have requested a court to issue an arrest warrant for Medytox C...
by Jeong Sae-im  |  2020-03-25 14:09
Will next-generation COVID-19 tests replace standard PCR checks?
Biotech companies are chasing new diagnostics to detect the new coronavirus...
by Jeong Sae-im  |  2020-03-25 11:40
KoBioLabs' allergic immune disease treatment enters global clinical trial
KoBioLabs, a company specializing in the microbiome, said Monday that it ha...
by Shim Hyun-tai  |  2020-03-23 16:03
Samsung Bioepis’ biosimilar breast cancer treatment scores FDA’s nod
Samsung Bioepis said Friday that the U.S. Food and Drug Administration has ...
by Lee Han-soo  |  2020-03-20 16:52
Back to Top